Alison Bennett

Alison Bennett

Liberal Democrat — Mid Sussex

Speaking in the House of Commons on 3 February 2025

Debate

AstraZeneca

Contribution

The Financial Times reports that, during its negotiations with the Government, AstraZeneca raised concerns about the vaccine plant, but also about the rejection of one of its breast cancer drugs and the drug pricing mechanism. Does the Minister agree that AstraZeneca’s rejection of his Government’s final offer is not the only concerning issue for our biopharma industry, and will he assure me that he is raising issues around the regulatory and reimbursement processes with the Health Secretary and the Treasury as barriers to growth in a sector already struggling with post-Brexit red tape?

More from Alison Bennett

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

For Alison Bennett's full parliamentary record including voting history, expenses and all other contributions, see the Alison Bennett report card.